Total Funding
90
45
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
254528
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Thomas Parr: Chief Scientific OfficerPast Role: Targanta Therapeutics, Chief Scientific Officer- Christopher Micetich: Founder, President & CEOPast Role: NAEJA-RGM Pharmaceuticals, Founder, President & CEO, Board Chairman
About the Company
Fedora Pharmaceuticals, a biotechnology company, engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs. It develops beta-lactamase inhibitor molecules, which are enzymes produced by bacteria that destroy the ring structure common to beta-lactam antibiotics, such as penicillin derivatives,
cephalosporins, monobactams, and carbapenems.
Fedora Pharmaceuticals’s products are used in combination with various beta-lactam antibiotics for the treatment of antibiotic infections currently resistant to therapy. It began operation in 2012, with its headquarters in Edmonton in Canada.
